Terms: = Bone cancer AND PDCD1, CD279, PD-1, PD1, SLEB2, hPD-1, hPD-l, hSLE1 AND Diagnosis
48 results:
1. Case Report: A novel mixture of dose-fractioned radiation and immunotherapy for treatment of cholangiocarcinoma.
Wang N; Wang L; Huang A; Han J; Cao T; Mei X; Yao J; Xiao Y; Ma H
Front Immunol; 2023; 14():1273962. PubMed ID: 38162668
[TBL] [Abstract] [Full Text] [Related]
2. Case report: Leptomeningeal metastasis of advanced nasopharyngeal carcinoma treated with chemoimmunotherapy.
Shi M; Sun D; Ma X; Liu J; Zhang Y; Liu T; Chen X; Mo S; Zhao Y; Zhang L
Hum Vaccin Immunother; 2023 Dec; 19(3):2294579. PubMed ID: 38111107
[TBL] [Abstract] [Full Text] [Related]
3. Immune checkpoint inhibitor induced colitis and arthritis: A case report.
Xie RX; Xue YB; Ci XY; Zhang MJ
Medicine (Baltimore); 2023 Dec; 102(49):e36334. PubMed ID: 38065892
[TBL] [Abstract] [Full Text] [Related]
4. Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitus.
Hilder R; Tsai K; Quandt Z; Isaacs D; Drakaki A; Xing Y; In GK; Angell TE; Lechner MG
Front Endocrinol (Lausanne); 2023; 14():1242830. PubMed ID: 38027216
[TBL] [Abstract] [Full Text] [Related]
5. Immune characteristics and prognostic implications of mucosal-associated invariant T cells in acute myeloid leukemia.
Peng Q; Huang R; Wang H; Xiao H; Wang Y; Zhai Z; Wang Z
Cancer Immunol Immunother; 2023 Dec; 72(12):4399-4414. PubMed ID: 37932426
[TBL] [Abstract] [Full Text] [Related]
6. Pediatric T-cell acute lymphoblastic leukemia blast signature and MRD associated immune environment changes defined by single cell transcriptomics analysis.
Bhasin SS; Thomas BE; Summers RJ; Sarkar D; Mumme H; Pilcher W; Emam M; Raikar SS; Park SI; Castellino SM; Graham DK; Bhasin MK; DeRyckere D
Sci Rep; 2023 Aug; 13(1):12556. PubMed ID: 37532715
[TBL] [Abstract] [Full Text] [Related]
7. Neoadjuvant pd-1/PD-L1 axis blockade for patients with head and neck squamous cell carcinoma.
Huang S; Xiong C; Tan K
Am J Otolaryngol; 2023; 44(6):103985. PubMed ID: 37442083
[TBL] [Abstract] [Full Text] [Related]
8. Inappropriate Expression of pd-1 and CTLA-4 Checkpoints in Myeloma Patients Is More Pronounced at diagnosis: Implications for Time to Progression and Response to Therapeutic Checkpoint Inhibitors.
Kulikowska de Nałęcz A; Ciszak L; Usnarska-Zubkiewicz L; Pawlak E; Frydecka I; Szmyrka M; Kosmaczewska A
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982802
[TBL] [Abstract] [Full Text] [Related]
9. Metastasis of breast cancer to bones alters the tumor immune microenvironment.
Chao X; Zhang Y; Zheng C; Huang Q; Lu J; Pulver EM; Houthuijzen J; Hutten S; Luo R; He J; Sun P
Eur J Med Res; 2023 Mar; 28(1):119. PubMed ID: 36915210
[TBL] [Abstract] [Full Text] [Related]
10. LAL deficiency induced myeloid-derived suppressor cells as targets and biomarkers for lung cancer.
Zhao T; Liu S; Hanna NH; Jalal S; Ding X; Wan J; Yan C; Du H
J Immunother Cancer; 2023 Mar; 11(3):. PubMed ID: 36914206
[TBL] [Abstract] [Full Text] [Related]
11. Multicentre real-world data of ramucirumab plus docetaxel after combined platinum-based chemotherapy with programmed death-1 blockade in advanced non-small cell lung cancer: NEJ051 (REACTIVE study).
Nakamura A; Yamaguchi O; Mori K; Miura K; Tamiya M; Oba T; Yanagitani N; Mizutani H; Ninomiya T; Kajiwara T; Ito K; Miyanaga A; Arai D; Kodama H; Kobayashi K; Kaira K
Eur J Cancer; 2023 May; 184():62-72. PubMed ID: 36905770
[TBL] [Abstract] [Full Text] [Related]
12. A PD-L1 Negative Advanced Gastric cancer Patient With a Long Response to pd-1 Blockade After Failure of Systematic Treatment: A Case Report.
Zhang F; Zhang J; Zhao L; Zhai M; Zhang T; Yu D
Front Immunol; 2021; 12():759250. PubMed ID: 34950137
[TBL] [Abstract] [Full Text] [Related]
13. Response to toripalimab combined with radiotherapy in advanced non-small cell lung cancer-not otherwise specified: A case report.
Jin Y; Xiao W; Wang X; Cui Y; Li B; Liu X
Medicine (Baltimore); 2021 Oct; 100(42):e27581. PubMed ID: 34678907
[TBL] [Abstract] [Full Text] [Related]
14. Partial response of metastatic cardia neuroendocrine carcinoma with the combined therapy involving pd-1 blockade after failed multi-line chemotherapies: a case report and literature review.
Yang Y; Xu H; Zhang L; Bai L; Zhu H; Li Q
Anticancer Drugs; 2022 Feb; 33(2):214-219. PubMed ID: 34620744
[TBL] [Abstract] [Full Text] [Related]
15. Deregulated Expression of Immune Checkpoints on Circulating CD4 T Cells May Complicate Clinical Outcome and Response to Treatment with Checkpoint Inhibitors in Multiple Myeloma Patients.
Kulikowska de Nałęcz A; Ciszak L; Usnarska-Zubkiewicz L; Frydecka I; Pawlak E; Szmyrka M; Kosmaczewska A
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502204
[TBL] [Abstract] [Full Text] [Related]
16. Increased frequency of TIGIT
Brauneck F; Haag F; Woost R; Wildner N; Tolosa E; Rissiek A; Vohwinkel G; Wellbrock J; Bokemeyer C; Schulze Zur Wiesch J; Ackermann C; Fiedler W
Oncoimmunology; 2021 Jun; 10(1):1930391. PubMed ID: 34211801
[TBL] [Abstract] [Full Text] [Related]
17. Recent Advances in Pathology: the 2021 Annual Review Issue of The Journal of Pathology.
Herrington CS; Poulsom R; Koeppen H; Coates PJ
J Pathol; 2021 Jul; 254(4):303-306. PubMed ID: 34097314
[TBL] [Abstract] [Full Text] [Related]
18. Sustained remission of multi-line relapsed extranodal NK/T-cell lymphoma, nasal type, following sintilimab and chidamide: A case report.
Xu J; Xu X; Chen J; Wang J; Jiang C; Lv C; Chen B
Medicine (Baltimore); 2021 Mar; 100(10):e24824. PubMed ID: 33725836
[TBL] [Abstract] [Full Text] [Related]
19. Research Status and Molecular Mechanism of the Traditional Chinese Medicine and Antitumor Therapy Combined Strategy Based on Tumor Microenvironment.
Zhang Y; Lou Y; Wang J; Yu C; Shen W
Front Immunol; 2020; 11():609705. PubMed ID: 33552068
[TBL] [Abstract] [Full Text] [Related]
20. A case of JAK2V617F-positive essential thrombocythemia where allele burden was reduced by a pd-1 inhibitor.
Hara R; Kawada H; Kikuti YY; Kikkawa E; Harada K; Aoyama Y; Ogiya D; Toyosaki M; Suzuki R; Machida S; Ohmachi K; Onizuka M; Ogawa Y; Masuda R; Iwazaki M; Nakamura N; Ando K
Int J Hematol; 2021 Apr; 113(4):606-610. PubMed ID: 33389657
[TBL] [Abstract] [Full Text] [Related]
[Next]
